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Food is a potent natural reward and food intake is a complex process. Reward and
gratification associated with food consumption leads to dopamine (DA) production, which
in turn activates reward and pleasure centers in the brain. An individual will repeatedly eat
a particular food to experience this positive feeling of gratification. This type of repetitive
behavior of food intake leads to the activation of brain reward pathways that eventually
overrides other signals of satiety and hunger. Thus, a gratification habit through a favorable
food leads to overeating and morbid obesity. Overeating and obesity stems from many
biological factors engaging both central and peripheral systems in a bi-directional manner
involving mood and emotions. Emotional eating and altered mood can also lead to altered
food choice and intake leading to overeating and obesity. Research findings from human
and animal studies support a two-way link between three concepts, mood, food, and
obesity. The focus of this article is to provide an overview of complex nature of food intake
where various biological factors link mood, food intake, and brain signaling that engages
both peripheral and central nervous system signaling pathways in a bi-directional manner
in obesity.
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INTRODUCTION
It is hypothesized that individuals engage in a variety of behav-
iors to regulate their mood (Morris and Reilly, 1987). Important
among mood regulating behaviors is food consumption. The
interaction between mood, emotional state, and feeding behav-
iors is complex and it is hypothesized that individuals regulate
their emotions and mood by changing both food choices and
quantities. It is also apparent that mood can affect the self-
rewarding mechanisms of food consumption (Morris and Reilly,
1987). Specific types of food tend to be preferred under cer-
tain psychological conditions due to the influence of foods on
the activity of brain reward centers (Figure 1) (Rangel, 2013;
Jauch-Chara and Oltmanns, 2014; Weltens et al., 2014). Positive
feedback loops can result in enhancement of appetite lead-
ing to obesity. Interestingly, highly palatable foods activate the
same brain regions of reward and pleasure that are active in
drug addiction (Volkow et al., 2012), suggesting a neuronal
mechanism of food addiction leading to overeating and obe-
sity (Davis et al., 2011, 2014; Dileone et al., 2012; Volkow
et al., 2012; Dagher, 2013; Davis, 2013; Ziauddeen and Fletcher,
2013; Pai et al., 2014; Potenza, 2014). Dopamine, which directly
activates reward and pleasure centers, affects both mood and
food intake (Cantello et al., 1989; Diehl and Gershon, 1992;
Fochtmann and Fink, 1992; Black et al., 2002; Cawley et al.,
2013), further supporting the link between psychology and eating
behaviors.
Mood disorders are often found in association with abnor-
mal feeding behaviors. For example, depression and anxiety are
comorbidities of obesity (Novick et al., 2005; Simon et al., 2006;
Kloiber et al., 2007). Impairment in central nervous system (CNS)
function has been linked to obesity that in turn impacts men-
tal and physical health (Allison et al., 2009; Talen and Mann,
2009; Duarte et al., 2010). Obese individuals are at increased
risk of developing depression (25, 26), and this risk is doubled
in the presence of diabetes (Anderson et al., 2001; De Groot
et al., 2001; Labad et al., 2010). Depressed mood is also asso-
ciated with abdominal obesity and poor diet (Roberts et al.,
2003; Dong et al., 2004; Simon et al., 2006; Luppino et al.,
2010; Zhao et al., 2011; Hamer et al., 2012). A link between
obesity and depression has been found in animal models of
mood disorders (Lombard, 2000; Pawels and Volterrani, 2008;
Dallman et al., 2003, 2005; Singh et al., 2007, 2009, 2011;
Dallman, 2010; Chuang et al., 2011; Diz-Chaves, 2011; Maniam
and Morris, 2012; Spence and Courbasson, 2012; Akubuiro et al.,
2013; Kumar et al., 2013), suggesting that a common signaling
pathway may underlie these phenotypes in both humans and
animals.
There are numerous articles on the regulation of food
intake, obesity, and mood. However, further exploration of
the interaction among mood, food, and obesity is much
needed. The aim of this review article is to highlight the
complex interplay among mood, emotional state, and eat-
ing behaviors that influence body weight. This review pro-
vides an overview of known biological factors and foods
that influence appetite and mood via brain signaling path-
ways. Specifically discussed are the foods and biological fac-
tors, which override the normal physiological requirements
of appetite regulation, and how these factors influence in a
bi-directional manner emotion, food, food intake, and obesity
(Figure 1).
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FIGURE 1 | Complex two-way relationship linking food intake, mood,
and obesity.
CENTRAL NERVOUS SYSTEM IN REGULATION OF MOOD,
FOOD, AND OBESITY
BI-DIRECTIONAL LINK OF FOOD AND EMOTION
In humans, eating behavior is complex and is affected by both
mood and emotions (Lyman, 1982; Mehrabian, 1995; Macht,
1999; Macht and Simons, 2000). However, mood and emotions
are distinct. Mood is characterized by psychological arousal in
the absence of obvious stimuli that can last for several min-
utes or longer. In contrast, emotions are short-term affective
response to reinforcing stimuli. Of all emotions, a study shows
that frequent emotions such as, anger and joy have the strongest
influence on appetite and food choice (Macht, 1999). Behavior
based findings from human studies of questionnaires, field, and
clinical studies suggest an integrative five way model that pre-
dicts five different aspects of emotional eating. These five aspects
include: food choice, food intake, loss of cognitive controls, food
modulating emotions, and emotion-congruent modulating eat-
ing, see review by Macht (2008). Therefore, depending on the
state of negative emotions or distress, emotional eating is trig-
gered where food intake can either increase or decrease within
the same individuals (Ouwens et al., 2009). Emotional state has
also been connected with addiction (Parylak et al., 2011). Sensory
and psychological pathways influence food choice, the quantity,
and meal frequency that may not be a part of normal physi-
ological requirement. Many psychosomatic theories of obesity
suggests that obese people overeat due to inability to perceive
their physiological state, hunger, and satiety and that overeating
reduce emotional discomfort and anxiety (Kaplan and Kaplan,
1957; Schachter, 1968; Bruch, 1985). The internal/external the-
ory of obesity predicts that normal eaters alter their food intake
to regulate their emotion, while obese people do not (Schachter,
1968; Canetti et al., 2002). Depending on whether an eater is
restrained or emotional, stress and negative emotions could be
associated with both increased and decreased motivation to eat;
and under those circumstances, food choice differs (Herman and
Mack, 1975). Thus, emotional distress influences emotional food
choice and intake.
STRESS AND FOOD INTAKE
There is a close interaction between food, mood, and stress
(Benton and Donohoe, 1999; Oliver and Wardle, 1999; Gibson,
2006; Dallman, 2010; Bast and Berry, 2014). Stress can affect feed-
ing behavior (Greeno and Wing, 1994; Yau and Potenza, 2013),
resulting in either increased or reduced food intake depending
on the types of external or psychological stressors (Oliver and
Wardle, 1999; Gibson, 2006; Dallman, 2010; Yau and Potenza,
2013). Similarly, chronic stress can lead to either increased con-
sumption of palatable and rewarding foods leading to obesity or
a diminished appetite leading to weight loss (Cartwright et al.,
2003; Adam and Epel, 2007; Tryon et al., 2013). Furthermore, fol-
lowing exposure to a stressor, studies show that intake of palatable
foods reduce signs of stress and anxiety (Pecoraro et al., 2004;
La Fleur et al., 2005; Maniam and Morris, 2010, 2012; Ulrich-Lai
et al., 2010; Finger et al., 2011, 2012). Interestingly, stress-induced
preference for palatable food is often seen in humans (Souquet
and Rowland, 1989; Epel et al., 2004; Pecoraro et al., 2004;
Christiansen et al., 2011; Gibson, 2012;Merali et al., 2013; Sharma
et al., 2013; Sharma and Fulton, 2013; Meye and Adan, 2014; Park
et al., 2014; Rho et al., 2014). Notably, this behavior is extended
to animals (Dallman et al., 2003, 2005; Cottone et al., 2009). This
suggests that a common neurobiological pathway maybe involved
in food choice and patterns of eating behavior during stress.
MOOD AND FOOD INTAKE
Mood states such as anxiety and depression affect food choice
and energy metabolism. Overeating and obesity is often associ-
ated with depression and anxiety in humans which has also been
reported in animal models (Novick et al., 2005; Simon and Von
Korff, 2006; Kloiber et al., 2007; Singh et al., 2007, 2009; Akubuiro
et al., 2013; Patterson and Abizaid, 2013; Sharma and Fulton,
2013). Both endocrine and metabolic conditions are exacerbated
in major depression (Mcelroy et al., 2004; Simon et al., 2006; De
Wit et al., 2010; Luppino et al., 2010; Marijnissen et al., 2011).
Individuals experiencing depressed moods show preference for
and consume palatable “comfort foods” as a mean to alleviate
their negative feelings (Macht, 2008). Although on a short-term
basis, palatable foods can provide some relief from negative emo-
tions and mood states, chronic consumption of calorically-rich
foods ultimately leads to obesity which in turn promotes vul-
nerability to depression and anxiety (Novick et al., 2005; Simon
et al., 2006; Kloiber et al., 2007; Sharma and Fulton, 2013).
Conversely, there are findings showing that prolonged high-fat
feeding leads to negative emotional states, increased stress sensi-
tivity, and altered basal corticosterone levels (Sharma et al., 2012).
Thus, negative emotion impacts food choice and intake that in
turns affects mood in a bi-directional manner.
Interestingly, other behaviors of reduced pleasure/reward
experience, anxiety-like behavior, and heightened stress-induced
hypothalamic pituitary adrenal axis (HPA) activation have been
found in mice. Furthermore, after exposure to chronic high-fat
diet and then switching to normal chow diet, mice showed craving
for sucrose, high-fat foods, and displayed enhanced anxiety-like
behavior (Sharma et al., 2012). Similar findings of increased
behavioral and physiological signs of depression and anxiety have
been reported in humans when switched from a high-fat sugar
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diet to regular diet (Avena et al., 2008; Teegarden and Bale, 2008;
Cottone et al., 2009; Pickering et al., 2009; Iemolo et al., 2012;
Sharma et al., 2012; Blasio et al., 2013). All together, these findings
suggest that chronic high-fat feeding promotes negative emo-
tional states and potentiates condition for enhanced sensitivity
to stress that leads to continuous repetitive cycles of overeating,
weight gain, and depressed mood.
FOOD PREFERENCE AND MOOD
Hippocrates, father of modern medicine, said: “Let your food be
your medicine, and your medicine be your food” (Prasad, 1998).
Research from human trials and animal studies have shown that
foods directly influence brain neurotransmitter systems which in
turn has effects on mood and performance by altering the brain
structure, chemistry, and physiology.Mood can also influence our
food choices and expectations on the effects of certain foods can
influence our sapiens. Some of those foods impacting mood are
discussed below and summarized in Table 1 (Spring et al., 1982-
1983; Rogers and Lloyd, 1994).
Chocolate has a strong effect on mood, generally increasing
pleasant feelings and reducing tension (Osman and Sobal, 2006;
Parker et al., 2006b; Cartwright et al., 2007; Fletcher et al., 2007).
Chocolate contains psychoactive chemicals such as andamines
that stimulate the brain and result in good mood (Ottley, 2000).
However, negative feelings are also associated with chocolate in
some women on weight loss regimes who experience guilt after
eating chocolate. The unique taste and feel from chocolate in the
mouth leads to chocolate craving due to sensory factors associ-
ated with chocolate eating (Macht andDettmer, 2006; Osman and
Sobal, 2006; Parker et al., 2006b; Cartwright et al., 2007; Fletcher
et al., 2007).
Caffeine, mostly consumed in the form of coffee and tea, not
only has stimulant effects on enhancing alertness, vigilance, and
reaction time but also increases anxiety in susceptible individuals
(Acquas et al., 2002; Rossi et al., 2010). Caffeine blocks adenosine
receptors in the brain and can relieve headaches, drowsiness, and
fatigue. Short-term caffeine deprivation in regular users results in
withdrawal symptoms (Rogers, 1995).
Omega-3 fatty acids, found in various foods can influence,
mood, behavior, neuroticism, and impulse control (Van Strater
and Bouvy, 2006; Conklin et al., 2007; Stahl et al., 2008). Omega-
3 fatty acids play a role in major depressive disorder, bipolar
disorder, schizophrenia, substance abuse, and attention deficit
disorder (Young and Martin, 2003; Parker et al., 2006a; Van
Strater and Bouvy, 2006; Stahl et al., 2008). Docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA), both members of the
omega-3 fatty acid family, contribute to the fluidity of the cell
membrane, and thereby play an important role in brain devel-
opment and function (Pawels and Volterrani, 2008). Low blood
levels of polyunsaturated omega-3 fatty acids are associated with
depression, implying a role in mood disorders (Lombard, 2000;
Sanchez-Villegas et al., 2007; Antypa et al., 2012; Moranis et al.,
2012; Kang and Gleason, 2013; Grosso et al., 2014).
Micronutrients, such as thiamine (vitamin B1), iron, and
folic acid, play a role in emotion. Thiamine containing foods
influence mood states (Benton et al., 1995). Improved thiamine
status increases well-being, sociability, and overall energy levels.
Insufficient amounts of thiamine are associated with impaired
mood and cognitive functioning (Benton et al., 1997; Benton and
Donohoe, 1999).
Iron deficiency represents one of the most common nutri-
tional problems worldwide. Iron deficiency anemia can result
in depressed mood, and problems with attention and lethargy
(Benton and Donohoe, 1999).
Folic acid plays an important role in the brain. Folic acid defi-
ciency is associated with depressed mood (Coppen and Bolander-
Gouaille, 2005; Young, 2007). Psychiatric patients often run the
risk of developing folic acid deficiency due to loss of appetite from
anticonvulsant drugs that inhibit folic acid absorption (Ottley,
2000). Collectively, these findings suggest foods influence mood.
Mood can influence food preference (Christensen and Brooks,
2006). Choice of eating palatable foods can either lead to com-
fort feeling or disgust. A good example of behavioral change that
is observed after taking a meal is altered mood. A general effect
of meal on behavior is observed from animals to humans where
hunger leads to irritability and meal intake leads to arousal and
alertness. Thus, a search for food is cultivated. Once satiety sets
in, sedentary and calm behaviors most likely have positive rather
than negative effect on mood (Macht and Simons, 2000; Macht
et al., 2003; Macht and Dettmer, 2006; Macht, 2008). A potential
internal information route on emotional behavior was first recog-
nized in 2001 where nutrients from gut were relayed to the brain
by the vagus nerve affecting emotions (Zagon, 2001). However,
the relationship of emotions, physiological arousal, and mood in
a given situation is significantly dependent upon on the subject’s
motivational state (Reid and Hammersley, 1999) and the individ-
ual’s personality trait of neuroticism that interacts withmood and
response to emotional stimuli (Dess and Edelheit, 1998).
The pathogenesis of both mood and metabolic disorders dur-
ing obesity can be triggered by certain diets (Wallin and Rissanen,
1994; Sanchez-Villegas and Martinez-Gonzalez, 2013). Diets like
Western diets that are rich in saturated fat and low in poly-
unsaturated and mono-unsaturated fatty acids tend to increase
the incidences of depression (Peet et al., 1998). On the other
hand, diet like the Mediterranean diet appears to reduce depres-
sion (Sanchez-Villegas and Martinez-Gonzalez, 2013; Sanchez-
Villegas et al., 2013). Furthermore, many reports show the
increased incidence of depression on diets that lack omega-
3 polyunsaturated fatty acids (PUFA) and that depression is
reduced when intake of PUFA is increased in both humans (Lin
and Su, 2007; Sanchez-Villegas et al., 2007; Oddy et al., 2011; Park
et al., 2012a) and rodents (Moranis et al., 2012; Park et al., 2012b).
Besides mood changes, high fat diets promote increased weight
gain, visceral adipose tissue, larger waist circumference, and more
cardiovascular disease mortality (Schulze et al., 2006; Molenaar
et al., 2009; Romaguera et al., 2009, 2010; Mozaffarian et al., 2011;
Estruch and Salas-Salvado, 2013; Nazare et al., 2013). The accu-
mulation of adipose tissue in abdominal stores leads to several
complications of obesity including insulin resistance leading to
metabolic syndrome (Despres et al., 2006; Tchernof and Despres,
2013). These changes also lead to neurobiological impairments
affecting mood disorders such as depression and anxiety (Weber-
Hamann et al., 2002; Van Reedt Dortland et al., 2013a,b). It
is believed that increased circulating plasma fatty acids such as
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Table 1 | Summary of biological factors and food influencing mood, emotions, food intake, and brain signaling pathways.
Foods and biological
factors
Influence on mood, emotion, food intake, and brain
signaling pathways
References
Chocolate Increases pleasant feeling, reduce tension, and results in
good mood via serotonin and cannabinoid receptors
signaling
Ottley, 2000; Osman and Sobal, 2006; Parker et al., 2006b;
Cartwright et al., 2007; Fletcher et al., 2007
Caffeine Enhances alertness and increases anxiety and results in
withdrawal symptoms in some individuals via cannabinoid
CB1 receptor signaling pathway
Rogers, 1995; Acquas et al., 2002; Rossi et al., 2010
Omega-3 fatty acids Influences neuroticism, mood, behavior, and plays a role in
mood disorders. Omega-3 fatty acids in receptor
functioning, neurotransmitters levels, and monoamine
metabolism are all implicated in depression (see review
Parker et al., 2006a)
Lombard, 2000; Young and Martin, 2003; Parker et al.,
2006a; Van Strater and Bouvy, 2006; Conklin et al., 2007;
Sanchez-Villegas et al., 2007; Stahl et al., 2008; Antypa
et al., 2012; Moranis et al., 2012; Kang and Gleason, 2013;
Grosso et al., 2014
Micronutrients Thiamine plays a role in emotion, mood states, and
cognitive functioning. The pathway is unknown
Benton et al., 1995, 1997; Benton and Donohoe, 1999
Iron Iron deficiency results in depressed mood and lethargy. The
pathway is unknown
Benton and Donohoe, 1999
Folic acid Folic acid deficiency is associated with depressed mood.
The pathway is unknown
Coppen and Bolander-Gouaille, 2005; Young, 2007
Ghrelin Linked to stress mediated food reward behavior,
depression, and anxiety via ghrelin receptor signaling
pathway
Schanze et al., 2008; Barim et al., 2009; Kluge et al., 2009,
2011; Perello et al., 2010; Chuang et al., 2011; Diz-Chaves,
2011; Kumar et al., 2013
Serotonin Linked to food intake, depression, and anxiety via serotonin
receptor signaling pathway
Wurtman and Wurtman, 1989; Benton and Donohoe, 1999;
Pepino et al., 2009; Shabbir et al., 2013
Dopamine Linked to food reward behavior and mood via dopamine
receptor signaling pathway
Cantello et al., 1989; Diehl and Gershon, 1992; Fochtmann
and Fink, 1992; Berridge, 1996; Black et al., 2002; Davis
et al., 2009; Cawley et al., 2013
Leptin Linked to food intake, depression, anxiety, and mood
disorder via leptin receptor signaling pathway
Collin et al., 2000; Asakawa et al., 2003; Lu et al., 2006;
Finger et al., 2010; Liu et al., 2010; Sharma et al., 2010;
Yamada et al., 2011; Guo et al., 2012, 2013
Adiponectin Linked to depression and mood disorder. May involve
adiponectin-induced inhibition of GSK-3β pathway
Arita et al., 1999; Maeda et al., 2001; Milan et al., 2002;
Cnop et al., 2003; Delporte et al., 2004; Ryo et al., 2004;
Leo et al., 2006; Narita et al., 2006; Hanley et al., 2007;
Weber-Hamann et al., 2007; Ye et al., 2007; Yilmaz, 2008;
Zeman et al., 2009; Jeong et al., 2012; Wilhelm et al., 2013
Resistin Indirect link to depression. The pathway is unknown Krsek et al., 2004; Silha et al., 2004; Weber-Hamann et al.,
2007; Lehto et al., 2010
Insulin Linked to mood, depression, anxiety and negative emotion
via insulin receptor signaling
Gustafson et al., 1999; Benedict et al., 2004; Koponen
et al., 2008; Akbaraly et al., 2009; Almeida et al., 2009;
Benoit et al., 2009; Kleinridders et al., 2009; Marks et al.,
2009; Pulkki-Raback et al., 2009; Grillo et al., 2011;
Chapman et al., 2013; Platt et al., 2013
palmitic acid enters the brain and impairs neurological function
(Tsuboi et al., 2013). Palmitic acid impairs leptin and insulin
receptor signaling in the hypothalamus and promotes weight gain
(Benoit et al., 2009; Kleinridders et al., 2009). Under these cir-
cumstances, obesity is promoted, as well as a negative emotional
state. In addition, leptin and insulin have been noted to influence
mood (Gonder-Frederick La et al., 1989; Lu et al., 2006; Lu, 2007;
Zeman et al., 2009; Ryan et al., 2012).
Furthermore, several studies have shown humans on high
fat diet manifest mood disorders like depression that correlates
positively with high serum palmitate (Tsuboi et al., 2013).
Similarly, rats on high fat diet display increased anxiety-like
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behavior, altered body weight, plasma insulin, leptin, and glu-
cose levels when compared to rats on iso-caloric olive oil high
fat diet that show no changes in body weight, glycaemia, lep-
tin, and insulin levels (Hryhorczuk et al., 2013). Thus, saturated
fats stimulate HPA disturbances and/or inflammation, leading to
anxiogenic-like behavior in animals and depression in humans.
All together these findings suggest an association between certain
foods and improved mood.
PSYCHIATRIC AND EATING DISORDERS
The Diagnostic and Statistical Manuals of Mental Disorders
(DSM-5), which was developed by the American Psychiatric
Association in 1994, reported disturbed eating behaviors in psy-
chiatric disorders (American Psychiatric Association, 2013). In
humans, melancholic depression is associated with hypercorti-
solism, anhedonia, hypophagia, and weight loss (Fisher et al.,
1997; Krishnan and Nestler, 2008; Ulrich-Lai and Herman, 2009;
Hammack et al., 2010; Carroll et al., 2012; Hryhorczuk et al.,
2013; Patterson and Abizaid, 2013; Schellekens et al., 2013b).
In contrast to atypical depression, the most common forms
of depression are characterized by reduced hypothalamic pitu-
itary adrenal axis (HPA) activity, increased appetite, carbohydrate
craving, and weight gain (Juruena and Cleare, 2007). Those with
abdominal obesity are associated with hyperactive HPA axis due
to an elevated response to corticotrophin releasing hormone
(CRH) stimulation and increased stimulated response to stress
(Pasquali, 2012).
Altered serum cortisol level is associated with depression
(Parker et al., 2003; Raison and Miller, 2003; Stetler and Miller,
2011). Altered cortisol, HPA axis, and food intake have been asso-
ciated with depression (Ulrich-Lai and Herman, 2009; Dallman,
2010; Schellekens et al., 2012a). The neuronal pathways that
regulate food intake, and circuitries that act via the HPA axis
are implicated in a complex two-way relationship of three
concepts between mood, food, and eating behavior (Figure 1)
(Kyrou and Tsigos, 2009; Ulrich-Lai and Herman, 2009; Dallman,
2010; Schellekens et al., 2012b, 2013b). It is noted that there
is an overlap in neural circuitry of food intake and stress
that likely reinforces a link between stress and feeding behav-
ior (Maniam and Morris, 2012). These overlapping circuitries
of HPA axis modulating feeding behavior and stress converge
on corticosterone hormone producing neurons in the paraven-
tricular nucleus (PVN). Thus, elevated glucocorticoid and a
dysfunctional HPA axis are common to both depression and
obesity.
Glucocorticoids exert multiple effects on metabolic,
endocrine, immune, and behavioral functions. Glucocorticoids
regulate reward and emotional processes via their receptors in
midbrain and limbic circuits (Arnett et al., 2011; Solomon et al.,
2012; Hryhorczuk et al., 2013; Patterson and Abizaid, 2013;
Wang et al., 2013). Glucocorticoids not only act peripherally to
maintain energy homeostasis but also centrally to modulate HPA
activity, emotional, and behavioral effects of stress (Fedoroff
et al., 2003; Figueiredo et al., 2003). Under physiologic acute
stress, the HPA axis is activated, and glucocorticoids are released.
This leads to a major restoration of energy balance by increasing
insulin, increasing motivation for palatable food (Piazza and Le
Moal, 1997; Dallman et al., 2006; Dallman, 2010), and mobilizing
stored energy toward central stores that leads to obesity (Mann
and Thakore, 1999). Thus, obesity and mood disorder are linked
via the HPA axis. In rodents, chronic corticosterone exposure
leads to increased glucocorticoid receptor (GC) expression in
fore-brain and basolateral amygdala that results in depressive-
like, anxiety-like behaviors, and increased locomotors (Wei et al.,
2004; Boyle et al., 2005, 2006). Therefore, these findings suggest
that a deficit in glucocorticoid signaling in distinct brain regions
may play a role in affective disorder.
OBESITY AND MOOD
Obesity increases incidence of anxiety and mood disorders
(Simon et al., 2006). Stress induced overeating and obesity is
also associated with major depression in humans (Novick et al.,
2005; Simon et al., 2006; Kloiber et al., 2007). Individuals under
chronic stress tend to have more visceral fat due to excessive
systemic cortisol levels (Brown et al., 2004; Adam and Epel,
2007; Kyrou and Tsigos, 2009). In all, there appears to be a
good association between hypercortisolemic depression, abdom-
inal fat accumulation (Weber-Hamann et al., 2002), decreased
glucocorticoid-mediated negative feed back, and increased cor-
ticotropin releasing hormone (CRH) release from the paraven-
tricular nucleus (PVN) (Holsboer, 2000). Furthermore, major
depression in adolescence is linked to a higher risk for obesity in
adulthood (Richardson et al., 2003). It is also noted thatmetabolic
conditions are exacerbated in depression and vice versa (Mcelroy
et al., 2004; Simon et al., 2006; De Wit et al., 2010; Luppino
et al., 2010; Marijnissen et al., 2011). Like-wise, stress significantly
impacts food intake in both humans and animals, thereby pro-
motingmetabolic disturbances (Block et al., 2009; Dallman, 2010;
Maniam and Morris, 2012). Overeating can also be considered
to be analogous to drugs of use because it reflects an addiction
where individuals become physically and psychologically depen-
dent on foods rich in fat and sugar (Avena et al., 2008, 2009; Barry
et al., 2009; Parylak et al., 2011; Allen et al., 2012; Davis, 2013).
Reports also show that with intake of palatable rewarding food,
acute stress responses are reduced (Dallman et al., 2003; Lutter
and Elmquist, 2009; Chuang et al., 2011; Kumar et al., 2013),
thereby showing the potential of “comfort eating” in stress relief.
All together these findings suggest that there is a reciprocal link in
mood disorder and obesity.
RODENT MODELS OF MOOD AND EATING DISORDERS
Rodent studies have provided the best insight into dopamine-
mediated food intake. Dopamine deficient mice die quickly due
to decreased food intake (Hnasko et al., 2004). Dopamine when
given in the striatum rescues deficient food intake by restarting
feeding behavior. Further, when dopamine is given to the nucleus
accumbens, a food preference for pleasant food vs. non-pleasant
food is observed. Altered dopamine receptor expression is also
associated with feeding behavior (Clifton et al., 1991; Zeng et al.,
2004; Wang et al., 2009) (18). Post-transcriptional modification
such as RNA editing could also play a role in altered reward cir-
cuitry mediating overeating behavior (18). It is noteworthy that
altered serotonin 2C receptor (5HT2CR) editing has been asso-
ciated with dopamine production, reward, mood, feeding, and
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recently obesity (Burns et al., 1997; Sodhi et al., 2001; Gurevich
et al., 2002; Higgins and Fletcher, 2003; Iwamoto et al., 2005;
Rosenzweig-Lipson et al., 2007; Berg et al., 2008; Olaghere Da
Silva et al., 2010; Hayes and Greenshaw, 2011; Schellekens et al.,
2012a). Intriguingly, both serotonergic and dopaminergic sys-
tem are altered in transgenic mice with dysregulated RNA editing
enzyme, ADAR2 (Singh et al., 2007, 2009, 2011) (18). These
transgenic mice show significantly hyperactive brain regions
implicated in reward and also behaviorally display goal oriented
behavior toward food in a competitive rewarding environment
(Akubuiro et al., 2013). Furthermore, altered dopamine recep-
tor expression, food preference for high fat diet are also observed
in ADAR2 transgenic mice (Akubuiro et al., 2013). Interestingly,
co-morbidities of depression and anxiety behaviors and altered
5HT2CR editing are observed in ADAR2 transgenic mice (Singh
et al., 2007, 2009, 2011). Collectively, these results suggest that
co-morbidities of affective disorder, overeating, and obesity could
be linked via the modified 5HT2CR in ADAR2 transgenic mice.
However, more studies are required to provide a better under-
standing of the post-transcription modification of the 5HT2CR
linking to mood, food, and obesity in ADAR2 transgenic mice.
Dysfunctional serotonergic signaling has been associated with
mood and obesity (Wurtman and Wurtman, 1989; Benton and
Donohoe, 1999; Sodhi et al., 2001; Iwamoto and Kato, 2003;
Schmauss, 2003; Kawahara et al., 2008; Morabito et al., 2010;
Singh et al., 2011; Schellekens et al., 2012a; Silberberg et al., 2012;
Shinozaki et al., 2013). In another rodent model of depression
brain derived neurotropic factor (BDNF) was shown to have an
antidepressant-like effect (Siuciak et al., 1997). BDNF has been
shown to be a neurotropic factor on serotonergic neurons in
BDNF heterozygous mice where dysfunctional serotonergic sig-
naling is associated with aggression, hyperphagia, and weight
gain is rescued (Lyons et al., 1999). Further exogenous BDNF
application enhances serotonin signaling and modifies several
behaviors regulated by serotonin feeding, body weight homeosta-
sis, and analgesia (Siuciak et al., 1994; Pelleymounter et al., 1995).
Thus, these studies suggest that dysfunctional serotonergic and
dopaminergic systems play a critical role in mood, food intake,
and obesity.
PSYCHOBIOLOGICAL RELATIONSHIP OF BRAIN REWARD LINKING
HUNGER, ADDICTION, OVEREATING, AND OBESITY
Continuous overeating can be viewed as an addictive behav-
ior that involve reward circuitry (Davis, 2013). Reward circuitry
involved in addiction spans two key brain regions, (1) the pre-
frontal region and the amygdala and, (2) the limbic system inte-
grating amygdala with hypothalamus and septal nuclei (Elliott
et al., 2000; Schultz, 2000, 2002; Tzschentke, 2001; Baxter and
Murray, 2002; Rolls et al., 2002; Koob and Volkow, 2010). The
neural mechanism of disrupted dopamine signaling pathways
being central to overeating and drugs of use and the overwhelm-
ing hallmarks of urge to seek and consume, thereby presents
an addiction behavior. Another common phenomenon of com-
pulsive intake of drugs and overconsumption of food intake
seen in obesity is the loss of control due to impairments in cir-
cuits involved in decision making, self control, interoception, and
regulation of mood and stress (Volkow et al., 2010).
Two hormones: ghrelin and leptin interact with the hypothala-
mus to regulate food intake, energy homeostasis, promote satiety,
and hunger. Interestingly, both hormones have been implicated in
craving behavior, eating disorder, and mood and have also been
associated with the reward pathway (Kiefer et al., 2001; Opland
et al., 2010; Dickson et al., 2011). Thereby, suggesting that both
ghrelin and leptin are linked to mood and food intake.
There are several neurotransmitter systems involved in feeding
such as serotonin, dopamine, opioids, and GABA, of which sero-
tonin and dopamine have been the most closely linked to feeding
behavior. Dopamine mediates reward specifically the “wanting”
or approach behaviors toward a biologically relevant goals more
so than “liking” or enjoyment aspect (Berridge, 1996; Davis et al.,
2009). Opioids have been implicated more so in the “liking” or
the hedonic aspect of reward processing and both neurotransmit-
ter pathways work together in the perception of reward (Davis
et al., 2009). The “wanting” behavior toward a biological rele-
vant goal that is mediated by dopamine is probably due to how
dopamine neurons receive signals and the way they are orga-
nized in the brain. Dopamine neurons are found in the midbrain
region of the ventral tegmental area (VTA) and substantia nigra
pars compacta projecting to striatal limbic and cortical regions.
Dopamine neurons receive information from; hypothalamus and
brain stem regions involved in autonomic responses, hippocam-
pus involved in memory, amygdala involved in emotional reac-
tivity, thalamus involved in arousal and prefrontal cortex and
cingulate involved in emotional reactivity via neuropeptides and
neurotransmitters. Neurochemistry and neuroanatomical reward
circuitry involved in addiction to alcohol and drugs translate to an
addiction model of overeating and obesity. Certain studies show
that hunger can influence memory for food-related stimuli where
the orbitofrontal cortex is specifically involved in food-related
stimuli in hunger state (Morris and Dolan, 2001). In rodent
studies, dopamine has been shown to play a role in feeding by
determining a meal size to meal duration, and obesity (Clifton
et al., 1991; Schwartz, 2000). Dopamine in the nucleus accumbens
has been associated with reinforcement aspects of food and while
in the hypothalamus, dopamine plays a role in initiation and
duration of feeding (Wang et al., 2004b). Leptin and insulin also
help to regulate dopamine production (Leinninger et al., 2009).
Dopamine regulates food consumption involving the mesolim-
bic pathway and the hypothalamus (Volkow et al., 2011). Since
dopamine levels in addiction change in these brain regions, it is
conceivable that a similar mechanism of reinforcement of food
may also be involved in food addiction (Wang et al., 2004b).
FOOD REWARD, ADDICTION, AND OBESITY
Food is a natural reward and has both homeostatic and hedonic
characteristics (Rada et al., 2010; Volkow et al., 2011). Depending
on the specific type of highly palatable food, it has the poten-
tial to engage similar brain reward pathways as drugs of abuse
(Weatherford et al., 1990; Pitchers et al., 2010; Olsen, 2011).
It may also arise from casual eating to compulsive eating that
eventually leads to addiction (Davis, 2013). This may be from
food-related brain changes that is associated with psychological
changes like that seen in drug addiction (Robinson and Berridge,
2003). Both rewarding and hedonic effects of food result in
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positive emotional reactions that play a major role in overeating
and obesity (Fulton, 2010; Avena et al., 2013; Bongers et al., 2013;
Sinha and Jastreboff, 2013; Yau and Potenza, 2013). Theoretical
models support food addiction because highly palatable food
activates reward pathways that lead to human and animal obe-
sity (Finlayson et al., 2007; Berner et al., 2008; Heyne et al., 2009;
Davis et al., 2011; Sampey et al., 2011; Akubuiro et al., 2013;
Davis, 2013).
The American Psychological Association in the DSM-5 man-
ual included behavioral addiction and addictions to natural
rewards as a new category of “addiction and related behavior”
(Volkow and O’brien, 2007). Human and rodent studies sug-
gest that dysregulated brain reward pathways may contribute
to increased intake of palatable food leading to obesity (see
review by Berthoud et al., 2011). Despite the divergence in eating
behavior, there is an overall increase in tasty, energy- rich foods
that is independent of stress-induced hyperphagia or hypophagia
(Gibson, 2006; Dallman, 2010). One hallmark of food addic-
tion is the food craving where intense desired food consumption
only compensates the craving, whereas in hunger various types
of food alleviates the hunger (Martin et al., 2011). Advantages
of functional magnetic resonance imaging (fMRI) and positron
emission topography (PET) paradigms have been used to pro-
vide insights of neural correlates in food addiction and obesity
(Wang et al., 2004a; Teegarden and Bale, 2007; Volkow et al.,
2012). Interestingly, following various types of food presentation
to normal healthy patients, activated brain regions of anterior
cingulate cortex, orbitofrontal cortex, and insula are observed
(Wang et al., 2004a; Teegarden and Bale, 2007). In contrast to
obese overeating patients, neurobiological changes in the reward
pathways are similar to those observed in drug addicts (Volkow
et al., 2012). However, available data in humans on food addic-
tion suggests that there is heterogeneity in the clinical definitions
of food addiction, obesity, and binge eating disorder. Nonetheless
through neurobiological data obtained from both human and
animal studies, food cravings, overeating, and tolerance sup-
port an addiction-like model, see reviews (Albayrak et al., 2012;
Volkow et al., 2012; Davis, 2013; Hone-Blanchet and Fecteau,
2014).
SOCIETY AND FOOD ADDICTION
Globally about 1 billion adults are overweight of which 475
million are obese (Organization, 2013). Obesity is a complexmul-
tifactorial disease. In the United States, increased incidence of
adult obesity is on the rise. In the Westernized society, the major
cause of obesity is due to reduced physical activity leading to
sedentary life style and surplus of food, sodas, variety of fast food,
and hyperpalatable foods, all that activate dopamine rewarding
centers leading to over consumption of food (Fortuna, 2012;
Granados et al., 2012; Ziauddeen et al., 2012). Hyper-palatable
foods and their increased availability promote addictive and com-
pulsive eating leading to weight gain. Addictive properties of
certain types of food and addiction-like behaviors are observed
in both humans and animal models. Animal studies have shown
an overview of addiction-like eating behaviors when presented
with foods high in sugar and fat (Avena et al., 2008, 2012).
In animals, several studies of sugar-binging models support an
addiction-like phenotype of tolerance, cross sensitization, with-
drawal, and neurochemical changes, but does not induce obesity
(Avena, 2007; Avena et al., 2008, 2009). On the other hand, several
imaging studies from obese population shows that greater BMI
and overeating are associated with neurobiological pathways sim-
ilar to those observed in drug addicts (Stice and Dagher, 2010;
Stice et al., 2010; Volkow et al., 2012, 2013). In humans, feed-
ing behaviors are more complex but pattern of food addiction
appears to parallel substance dependence (Gearhardt et al., 2011;
Dileone et al., 2012). Some argue that food addiction should be
included in the DSM manual (Volkow and O’brien, 2007; Taylor
et al., 2010) even though food addiction is not a categorized diag-
nosis within DSM-5. However, recently Yale Food Addiction Scale
(YFAS) has been used as a tool for diagnosis of food addiction
in patients with eating disorders (Gearhardt et al., 2009; Clark
and Saules, 2013). In one study, using body mass index, body
fat percentage by dual-energy X-ray absorptiometry, macronu-
trient intake, and the YFAS scale has been used as a diagnostic
tool to assess food addiction in general Newfoundland popula-
tion (Pedram et al., 2013). They found that the prevalence of
food addiction was significantly associated with obesity in gen-
eral population. Thus, suggesting that food addiction contributes
to severity of obesity in the general population and that food
addiction could be a separate etiology of obesity.
In summary, findings of central mediated food intake suggest
a complex two-way link between food intake and mood, emo-
tion, reward, food, food choice, and neurotransmitters (Figure 1).
Food addiction remains as an incomplete described phenomenon
due to limited data. Overabundance of food seems to aid in food
addiction specifically foods rich in fat and sugar. Although FMRI
and PET imaging have been useful in providing some insights
into neural correlates in food addiction and obesity, but specific
food addiction phenotype in the development of obesity needs to
be differentiated. Furthermore, molecular pathways or signatures
that link food intake in emotion, mood, food, reward, and obesity
are areas that need further investigation. These types of studies in
the future will provide further insight into genetic, psychological,
neuropsychiatric, and environmental risk factors associated with
overeating, food addiction, and obesity.
PERIPHERAL SYSTEM IN REGULATION OF MOOD, FOOD,
AND OBESITY
The gut-brain axis mediates the communication between brain
and gut when it comes to appetite, satiety, and energy home-
ostasis (Cummings and Overduin, 2007; Ahima and Antwi, 2008;
Blevins and Baskin, 2010; Gibson et al., 2010; Suzuki et al.,
2010, 2012). Furthermore, peripheral hormones have also been
reported to regulate mood, food intake, and obesity (Tschop
et al., 2000; Nakazato et al., 2001; Olszewski et al., 2008; Blevins
and Baskin, 2010; Suzuki et al., 2010; Andrews, 2011b; Dickson
et al., 2011; Egecioglu et al., 2011; Skibicka and Dickson, 2011;
Overduin et al., 2012; Perello and Zigman, 2012; Karra et al.,
2013). Gastrointestinal signals such as cholecystokinin (CCK),
bombesin, glucagon eneterostatin, insulin, resistin, somatedin,
cyclohistiyl-proline, leptin, amylin, and apolipoprotein A-IV are
all known to reduce food intake. The exception is ghrelin, which
increases food intake. Several peripheral factors that engage the
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CNS in a bi-directional manner and influence mood and food
intake are summarized in Table 1 and discussed below.
GHRELIN
A gut orexigenic hormone ghrelin is synthesized in the stomach
and acts centrally to mediate increased food intake via cen-
tral pathways (Kojima et al., 1999, 2004; Tschop et al., 2000;
Nakazato et al., 2001; Andrews, 2011a; Diz-Chaves, 2011). The
hypothalamus in the brain directly senses peripheral ghrelin and
modifies the energy status (Schaeffer et al., 2013). Studies sup-
port that ghrelin reaches the brain via the vagus afferents to
the nucleus solitary tract (NST), which further projects to the
arcuate nucleus of the hypothalamus (Asakawa et al., 2001; Date
et al., 2002; Williams and Mobarhan, 2003). Ghrelin activates
downstream signaling via the hormone secretagogue receptor
(GSH-R1a) where it is ubiquitously expressed in multiple brain
regions and in peripheral tissues. Due to multiple sites of GSH-
R1a expression, it is not surprising that ghrelin performs many
other biological activities of growth hormone secretion, glucose
and lipid metabolism, and gastrointestinal motility. However,
other properties of GHS-R1a allowing dimerization with multi-
ple G-protein coupled receptors suggest the likelihood of cross
talk between many other neuropeptide systems of serotonin and
dopamine (Schellekens et al., 2013a,b). Thus, ghrelin has the
potential to engagemultiple neuropeptide systems inmood, food,
and obesity.
The ghrelinergic system also mediates the non-homeostatic
hedonic rewarding and motivational aspects of food intake
via mesolimbic dopaminergic circuitry (Dickson et al., 2011;
Egecioglu et al., 2011; Skibicka et al., 2011; Perello and Zigman,
2012). Studies support ghrelin’s involvement in stress mediated
food reward behavior (Perello et al., 2010; Kumar et al., 2013;
Chuang et al., 2011; Diz-Chaves, 2011). Numerous studies pro-
vide a link between ghrelin and affective disorders, such as depres-
sion and anxiety (Schanze et al., 2008; Barim et al., 2009; Kluge
et al., 2009). Ghrelin also alleviates depression (Kluge et al., 2011).
All together these studies suggest that the ghrelinergic system is an
attractive system to target stress associated metabolic and mood
associated eating disorders in obesity.
SEROTONIN
Serotonin has numerous functions besides regulating mood
that includes regulation of sleep, appetite, and impulse con-
trol (Steiger, 2004; Daubert and Condron, 2010; Nordquist and
Oreland, 2010; Mosienko et al., 2012). Serotonin levels from
the gut and alimentary canal constitutes about 80–90% of the
human body’s total serotonin and not in the brain. This is sur-
prising, as serotonin dictates most of our mood and happiness
(Wurtman and Wurtman, 1989; Benton and Donohoe, 1999).
Central serotonin pathways participate in the regulation of mood
and modulate meal patterns in terms of quality and quantity.
Neurotransmitter release of serotonin from serotonergic neurons
in the brain is governed by food intake (Shabbir et al., 2013).
The essential amino acid tryptophan that comes from food is
the precursor for serotonin synthesis (Prasad, 1998). Ingestion of
carbohydrates increases the plasma ratio of tryptophan to other
large neutral amino acids leading to increased serotonin synthesis
in the brain and alleviating depression. Such is the case for car-
bohydrate craving during depression that often leads to obesity
and vice versa (Pepino et al., 2009; Shabbir et al., 2013). This
is observed during stress, winter depression, or in people trying
to give up smoking. Nicotine increases brain serotonin secre-
tion and its withdrawal leads to depression (Wallin and Rissanen,
1994;Wurtman andWurtman, 1996). Brain serotonin plays a role
in the pathophysiology of depression, as treatments with sero-
tonin potentiating drugs alleviates depression in seasonal affective
disorder (Wurtman, 1993). Based on these findings it has been
suggested that the excessive carbohydrate intake by patients with
premenstrual syndrome (PMS) and seasonal affective disorder
(SAD) relieves the depressive symptoms via an increased cen-
tral serotonergic activity (Cizza et al., 2005; Miller, 2005). A diet
rich in carbohydrates can relieve depression and elevate mood
(Wurtman and Wurtman, 1989; Benton and Donohoe, 1999).
Furthermore, research has shown that dieters tend to become
depressed as the serotonin levels are reduced due to decreased car-
bohydrate intake (Huether et al., 1997). Thus, these studies imply
that certain foods are strong mood regulators.
LEPTIN
Low leptin levels have been found to be associated with human
depression and depression-like behaviors in rodents (Kraus et al.,
2001; Lu et al., 2006; Guo et al., 2012; Lawson et al., 2012).
Antidepressant-like effect of leptin in leptin insufficiency or lep-
tin resistance suggests the hormone contributes to altered mood
(Lu, 2007). Increased visceral fat and dyslipidemia are associ-
ated with several endocrine and metabolic changes that link to
CNS control of emotional states and mood (Hryhorczuk et al.,
2013). As an endocrine gland, adipose tissue secretes numerous
peptide hormones that target the brain and peripheral tissues
to regulate metabolism and behavior. Leptin circulates in pro-
portion to fat mass (Maffei et al., 1995). Leptin impacts several
physiological processes such as appetite, energy expenditure, and
neuroendocrine function. The hormone has also been linked to
human depression and has been shown in rodents to have antide-
pressant and anxiolytic effects (Asakawa et al., 2003; Liu et al.,
2010; Yamada et al., 2011; Lawson et al., 2012). Nevertheless, there
are conflicting findings of leptin levels and depression, which are
discussed below.
Major depressive disorder (MDD) has been shown to be asso-
ciated with lower plasma leptin levels when compared to healthy
controls (Kraus et al., 2001; Atmaca et al., 2002, 2008; Westling
et al., 2004; Jow et al., 2006). On the other hand, there are reports
showing increased plasma leptin levels in depression (Kraus et al.,
2002; Esel et al., 2005; Schilling et al., 2013), gender specific
increased leptin levels in women with depressive disorder (Rubin
et al., 2002; Esel et al., 2005; Zeman et al., 2009), as well as no
changes of leptin by antidepressant treatment (Esel et al., 2005).
In depressed individuals suffering from loss of appetite, plasma
leptin levels do not differ from those of healthy controls (Deuschle
et al., 1996). In another study, it was found that higher serum lep-
tin was associated with atypical depressive patients with increased
appetite (Gecici et al., 2005). In older men, a combination of
elevated visceral fat and high leptin levels was associated with
depression (Milaneschi et al., 2012), and high leptin correlated
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positively with depressive symptoms in patients with type 2 dia-
betes (Labad et al., 2012). Thus, these reports suggest more
studies are required to draw a better conclusion regarding the role
of leptin in human depression.
Interestingly, rodent studies have provided themost conclusive
findings. Leptin modulates the HPA axis and mice that lack lep-
tin (obese ob/ob mice or its leptin receptor (obese db/db mice)
show increased depression-like behavior (Collin et al., 2000;
Asakawa et al., 2003; Lu et al., 2006; Finger et al., 2010; Liu
et al., 2010; Sharma et al., 2010; Yamada et al., 2011; Guo et al.,
2012, 2013). Furthermore, leptin deficient ob/ob mice have ele-
vated corticosterone that can be reduced by leptin replacement
(Garthwaite et al., 1980; Arvaniti et al., 2001). In contrast, chronic
unpredictable mild stress in rats activates the HPA axis and
leads to depressive-like behaviors that correlate with decreased
serum leptin levels (Ge et al., 2013). Leptin receptors (LepRb) in
midbrain and forebrain loci that affect emotional processes are
targeted by leptin. Genetic deletion of LepRb in the hippocam-
pus results in a depression-like phenotype, which is reduced
by leptin administration to the hippocampus thereby showing
an antidepressant effects (Asakawa et al., 2003; Lu et al., 2006;
Finger et al., 2010; Liu et al., 2010; Guo et al., 2013). Loss of
LepRb specifically in glutamatergic neurons of the forebrain elic-
its depressive-like behavior without affecting anxiety (Guo et al.,
2012). Stress-induced dopamine release is also associated with
high leptin (Burghardt et al., 2012). Leptin activates dopamine
neurons in the VTA of the midbrain reducing dopamine neuronal
firing and increases dopamine availability (Fulton et al., 2006;
Hommel et al., 2006). Selective deletion of LepRb from midbrain
dopamine neurons results in increased anxiety-like behavior, but
not depressive-like behavior (Liu et al., 2011). LepRb signal-
ing in limbic and prefrontal nuclei mediates the antidepressant
action of leptin. In contrast, leptin in dopamine neurons of the
ventral midbrain and in central nucleus of the amygdala lep-
tin signaling exerts the anxiolytic actions of leptin. Thus, leptin
signaling in different brain regions exerts different physiological
behaviors.
In conditions of central obesity that favors insulin resis-
tance and type 2 diabetes, leptin sensitivity is diminished.
Leptin resistance is associated with high plasma leptin levels
and defective LepRb signaling. These states are characteristic
of obesity and increase the risk for mood disorders (Myers
et al., 2012). Mice made obese by a high fat diet intake
show reduced sensitivity to effects of leptin and antidepres-
sant actions of leptin when compared to low-fat diet treated
controls (Yamada et al., 2011). Further, leptin insensitivity exac-
erbates HPA dysregulation in obesity (Komorowski et al., 2000;
Collura et al., 2009) and thereby enhances the mass of dys-
functional central adipose stores in a cortisol-dependent man-
ner. Leptin resistance has been reported to be associated with
the mid brain VTA where mesolimbic DA neurons reside
(Matheny et al., 2011). Leptin resistance appears to affect mul-
tiple neural and endocrine pathways including hippocampal,
mesolimbic dopamine pathways, and HPA activity ultimately
affecting emotions and mood. Thus, these studies provide evi-
dence of leptin related mechanisms underlying depression in
obesity.
ADIPONECTIN
Low levels of another adipose-derived hormone, adiponectin, has
been implicated in energy homeostasis, metabolic disturbances,
insulin resistance (Kennedy et al., 2006; Hanley et al., 2007; Turer
and Scherer, 2012; Hryhorczuk et al., 2013) and recently, depres-
sion in humans (Arita et al., 1999; Cnop et al., 2003; Ryo et al.,
2004; Leo et al., 2006; Narita et al., 2006; Hanley et al., 2007;
Weber-Hamann et al., 2007; Yilmaz, 2008) and rodents (Maeda
et al., 2001; Milan et al., 2002; Delporte et al., 2004; Ye et al.,
2007). Changes in adiponectin levels are secondary to metabolic
disturbances in obesity (Morrison et al., 2011; Doumatey et al.,
2012). There are conflicting reports of either positive or negative
associations of adiponectins levels with mood disorder (Yilmaz,
2008; Zeman et al., 2009; Jeong et al., 2012; Wilhelm et al.,
2013), or no changes in patients with major depressive disorder
or with antidepressants (Lehto et al., 2010; Jeong et al., 2012).
Mice exposed to chronic social defeat recapitulate the low lev-
els of adiponectin, stress-induced depressive-like behaviors, and
impaired HPA axis (Liu et al., 2012). Interestingly central admin-
istration of adiponectin has antidepressant effects (Liu et al.,
2012). Thus, a link between plasma adiponectin levels and depres-
sion is observed in mice. In contrast, humans showmore ambigu-
ous results depending on the type of depressive disorder, sex, and
treatment.
RESISTIN
Adipocyte-derived resistin is linked to insulin resistance in rodent
models of depression-like behavior while in humans, the role of
resistin is less defined (Schwartz and Lazar, 2011; Hryhorczuk
et al., 2013). In genetic and diet induced obese mice circulat-
ing resistin levels are elevated (Steppan et al., 2001). In contrast,
resistin is down regulated in human obesity (Way et al., 2001;
Degawa-Yamauchi et al., 2003; Owecki et al., 2011; Sadashiv et al.,
2012). However, there is one study that shows a positive correla-
tion between resistin levels and atypical depression (Lehto et al.,
2010). In human depression, however, resistin levels positively
correlate with salivary cortisol (Krsek et al., 2004; Silha et al.,
2004; Weber-Hamann et al., 2007). Conversely, resistin levels are
lower in patients receiving antidepressant treatment who have
remitted from depression (Weber-Hamann et al., 2007). Thus,
these studies imply that resistin plays a role in affecting mood.
INSULIN
From a recent systematic review and meta-analysis there appears
to be a significant cross-sectional association between depres-
sion and insulin resistance (Kan et al., 2013) and there is a
bi-directional association between diabetes and depressed mood.
Depression is associated with pre-diabetes insulin resistance
(Anderson et al., 2001; Kan et al., 2013) and obesity (Hamer et al.,
2012). However, there exists a weak association of insulin resis-
tance and depression (Adriaanse et al., 2006; Platt et al., 2013;
Shen and Bergquist-Beringer, 2013). High fat diet intake impairs
the hypothalamic insulin receptor signaling (De Souza et al.,
2005; Kim and Feldman, 2012) and reduced hypothalamic insulin
signaling promotes weight gain and negative emotional states
(Gustafson et al., 1999; Koponen et al., 2008; Akbaraly et al., 2009;
Almeida et al., 2009; Benoit et al., 2009; Kleinridders et al., 2009;
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Pulkki-Raback et al., 2009; Platt et al., 2013). Intranasal insulin
ameliorates self-reported mood, reduce cortisol levels, and vis-
ceral obesity (Benedict et al., 2004; Chapman et al., 2013). Further
treating patients with major depressive disorder and abdominal
obesity, the insulin-sensitizing drug pioglitazone shows reduced
sign of depression, anxiety, and reduced insulin resistance (Kemp
et al., 2012).
In rodents, reduced insulin receptor signaling impacts mood
when placed on a long-term 30%kcal fat diet that shows anxi-
olytic effects (Marks et al., 2009). Similarly, rosiglitazone admin-
istered to normal chow-fed mice and rats show an antidepressant
action in behavioral despair tests (Eissa Ahmed et al., 2009; Ryan
et al., 2012). Antisense RNA targeting the insulin receptor in
rats results in increased depression-like behavior and anxiety-like
behavior (Grillo et al., 2011). By and large, these results sug-
gest that insulin signaling is involved in mood. However, further
studies are required to determine whether intranasal insulin has
antidepressant effects in depressed individuals and, if so, whether
this action is maintained in obesity.
To summarize, food intake is regulated by the peripheral
and central system that are engaged in a bi-directional manner.
Peripheral signals mostly modulate satiety and indicate adiposity
signal to the brain. Ghrelin is the only peripheral hormone that
induces hunger but interestingly it is also involved in mood and
hedonic aspects of food intake. There are several brain regions
involved in food intake that overlaps brain areas involved in
drugs of abuse and reward. Overlapping brain regions of reward,
mood, and food intake suggests that molecular changes in these
regions may provide further insights in to distinct and overlap-
ping pathways that could aid in understanding clinical treatments
of comorbidity of mood disorder, overeating, and obesity.
EPIGENETICS, MOOD, AND EATING DISORDER
Interaction of genes and environment has been associated with
mood disorders, see review Archer et al. (2013), and eating disor-
ders, see review Pjetri et al. (2012). Exposure to highly palatable
foods rich in fat and carbohydrate induces craving. In an obeso-
genic environment, repetitive exposures to highly palatable food
options increase the likelihood of food addiction, overeating, and
obesity. There appears to be a complex interaction between genet-
ics and environmental factors such as nutrition with neuropsy-
chiatric, neurodevelopmental, and neurodegenerative disorders.
Individual variability in numerous protein coding and non-
coding regions in the genome could be related to eating disorders
and affective disorders. Epigenetics mechanisms of DNA methy-
lation, RNA editing, post-translational modification of histones,
and non-coding RNAs regulate gene regulation without changing
DNA sequence in response to changes in internal and exter-
nal environmental variables. Epigenetics in the context of eating
disorders is interesting as it has the potential to answer numer-
ous questions including potential risk factors such as maternal
nutrition and stress that alter the risk of eating disorders in the
offspring. Unknown questions like how epigenetic modification
responds to acute changes like malnutrition or exposure to highly
palatable food needs to be answered. Furthermore, epigenetics in
learning and memory could also play a critical role in develop-
ment and maintenance of eating disorders. RNA editing of the
5HT2CR has been implicated in affective disorder, stress, mater-
nal separation, Prader Willi Syndrome, hyperphagia, and obesity
(Iwamoto and Kato, 2003; Englander et al., 2005; Iwamoto et al.,
2005; Bhansali et al., 2007; Kawahara et al., 2008; Morabito et al.,
2010; Singh et al., 2011; Schellekens et al., 2012a, 2013b,c). RNA
editing of the 5HT2CR alters many facets of serotonin signaling
via 24 different receptor isoforms. These edited 5HT2CR iso-
forms are in a distinct ratio in different brain regions suggests
an important role in linking mood, food intake and obesity via
the 5HT2CR. Therefore, future research in defining the role of
different isoforms in different brain regions is much needed to
understand the regulation of RNA editing and mood disorder by
the serotonergic system.
CONCLUSION
More than a third of adults and 17% of children and teenagers
in the United States are obese (Ogden et al., 2014). Obesity is
the second-leading cause of preventable death in the U.S. con-
tributing to 300,000 deaths each year. In addition, the health
care burden in obesity-related diseases in the U.S. could reach at
staggering $861–957 billion by 2030 (Go et al., 2013a,b, 2014).
This article points to biological factors engaging both central and
peripheral system in a bi-directional manner linking food intake,
mood, and obesity. Food intake is complex due to influence of
several factors. The influence of food choice includes biological
determinants of hunger, appetite, and taste. Besides these, other
factors of cost, income, and availability also influence food choice.
Other determinants of social and psychological factors of mood,
stress, and emotion also play a critical role in food choice. Many
people find it hard to stop eating a particular food even though
they are not hungry. Such behaviors activate the brain reward
center and alter the brain structure. Willpower has been specu-
lated in the past to control overeating. Through neurobiological
data, presence of food cravings, over eating, and tolerance support
an addiction-like model by numerous signals that are involved
in engaging both the central and peripheral nervous system in
a bi-directional manner to regulate food intake. Genes, environ-
ment, various emotions also influence food intake, and mood
states that trigger eating of palatable foods for comfort in nega-
tive emotional states. This repetitive eating of comfort foods, rich
in carbohydrate, high-fats and sugar, leads to obesity. Obesity in
turn regulates mood due to metabolic disturbances. Metabolic
disturbances further alter brain-signaling systems leading to a bi-
directional vicious cycle of mood, food, and obesity (Figure 1).
Furthermore a complex regulation of mood and eating disorders
are implied from emerging studies of epigenetics in mood and
eating disorders.
FUTURE DIRECTIONS
It is recognized that animal and human findings do not entirely
overlap, but animal studies have provided the most compelling
neurobiological findings of addictive nature of food, overeating,
food addiction, and obesity. In the future, using molecular studies
toward an effort to understand the environment of plentiful food
leading to obesity rather than food restriction in animal mod-
els will provide a valuable insight into the molecular mechanism
of overeating and food addiction. Further, using animal models
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and molecular studies in the area of withdrawal induction model
in highly palatable diet are needed. Understanding how brain
regions are altered with various nutrients, in depression, anxiety
state may elucidate a common overlapping brain region in co-
morbidities of affective and eating disorders. Epigenetic progress
in relation to eating disorder has been slow. Molecular pathways
of regulated non-coding RNAs in gene regulation involved in
affective disorders and overeating may provide novel pathways
involved in the pathogenesis. Epigenetic regulation of primary
brain signaling and factors governing their metabolism needs
further investigation where animal studies are likely to guide psy-
chiatric analysis of epigenetic modification. Furthermore, next
generation sequencing can be useful in finding novel long and
small non-coding RNAs, alternative spliced RNAs, expression
levels of coding RNAs, and RNA editing changes in the clin-
ical treatment responders vs. non-treatment responders. It is
anticipated these future studies will aid in the development of
more targeted and effective therapies for preventing and treating
comorbidities of mood disorder and obesity.
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